Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Trickle Portfolio -- Ignore unavailable to you. Want to Upgrade?

To: Biomaven who wrote (44)	11/1/2000 1:59:21 PM
From: tuck	Read Replies (1) \| Respond to of 1784

Concerning IGEN and other special situations in the trickle category: should the Trickle Portfolio invest only in "paradigmatic" trickle stocks, avoiding potentially profitable near term plays because they are the culmination of a special situation? Do you think IGEN's underlying business is overvalued? It's hard to know if the recent run up is more related to earnings or potential for favorable settlement. I get the idea this is a fake out, since this low volume sell off is happening after a run, but before the news. It still seems cheap, just a few bucks over what insiders recently paid for it. Cheers, Tuck